Cargando…
Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma
Transglutaminase 2 (TG2) is a multifunctional crosslinking enzyme that displays transamidation, protein disulfide isomerase, protein kinase, as well as GTPase and ATPase activities. TG2 can also act as an adhesion molecule involved in the syndecan and integrin receptor signaling. In recent years, TG...
Autores principales: | Nezir, Ayca Ece, Ulukan, Burge, Telci, Dilek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409915/ https://www.ncbi.nlm.nih.gov/pubmed/30736384 http://dx.doi.org/10.3390/medsci7020024 |
Ejemplares similares
-
Role of Tissue Transglutaminase Catalytic and Guanosine
Triphosphate-Binding Domains in Renal Cell Carcinoma Progression
por: Ulukan, Burge, et al.
Publicado: (2020) -
A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2
por: Kim, Soo-Youl, et al.
Publicado: (2020) -
Discovery of a novel target for renal cell carcinoma: transglutaminase 2
por: Kang, J H, et al.
Publicado: (2016) -
Transglutaminase 2 Expression and Its Prognostic Significance in Clear Cell Renal Cell Carcinoma
por: Park, Min Jee, et al.
Publicado: (2015) -
Dual-Inhibition of mTOR and Bcl-2 Enhances the Anti-tumor Effect of Everolimus against Renal Cell Carcinoma In Vitro and In Vivo
por: Nayman, Ayse Hande, et al.
Publicado: (2019)